You are here

  • Home
  • Archive
  • Volume 24, Issue Suppl 1
  • CP-009 Risk assessment of diabetes ketoacidosis in type 2 diabetes mellitus patients treated with sodium–glucose cotransporter type 2 inhibitors

Article metrics

Article menu
Download PDFPDF
Clinical pharmacy
CP-009 Risk assessment of diabetes ketoacidosis in type 2 diabetes mellitus patients treated with sodium–glucose cotransporter type 2 inhibitors

 

Online download statistics by month:

Online download statistics by month: February 2017 to March 2024

AbstractFullPdf
Feb 2017500
Mar 20171006
Apr 2017600
May 20171400
Jun 2017401
Jul 20171200
Aug 20172606
Sep 20171801
Oct 20171402
Nov 20171200
Dec 2017800
Jan 2018800
Feb 20185004
Mar 20181000
Apr 20181800
May 20183600
Jun 20181000
Jul 20182200
Aug 20184800
Sep 20181400
Oct 20181001
Nov 20181800
Dec 20181200
Jan 20191600
Feb 20192000
Mar 20191700
Apr 2019601
May 2019800
Jun 2019400
Jul 2019600
Aug 20191000
Sep 20191400
Oct 20191400
Nov 2019800
Dec 20191000
Mar 2020200
Apr 2020100
May 20201800
Jun 20201000
Jul 2020600
Sep 20201000
Oct 20204200
Nov 20205000
Dec 2020600
Jan 20211601
Feb 2021800
Apr 2021600
Jun 2021003
Aug 2021500
Sep 2021003
Oct 2021200
Nov 2021600
Dec 20211600
Jan 2022601
Feb 2022200
Mar 2022202
Apr 2022400
May 20221000
Jun 20221800
Jul 20221400
Aug 2022200
Sep 2022400
Oct 2022200
Nov 2022800
Dec 2022400
Jan 2023400
Feb 2023800
Mar 2023400
Apr 20232800
May 2023800
Jun 2023700
Jul 2023600
Aug 2023400
Sep 2023200
Oct 2023200
Nov 2023400
Dec 2023400
Jan 2024200
Feb 2024200
Mar 20241401
Total897033